questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to CAR-T therapy for mantle cell lymphoma patients who previously have been ineligible under the cancer drugs fund following NICE's most recent decision.
answerText: Decisions on whether new medicines should be routinely funded by the National Health Service in England are made by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of their costs and benefits. NICE is currently r...
heading: Blood Cancer: Immunotherapy